Theseus Pharmaceuticals Inc THRX

NAS: THRX | ISIN: US88369M1018 13/02/2024

4,060 USD (0,00%)

(0,00%) 13/02/2024

Grafiek Theseus Pharmaceuticals Inc

Grafiek Theseus Pharmaceuticals Inc

1 dag1d 0,00%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m -0,49%
6 maanden6m 75,76%
1 jaar1j -64,63%
5 jaar5j -78,15%

Theseus Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

14 februari 2024 · Theseus Pharmaceuticals Announces Closing of Tender Offer · Persbericht

6 februari 2024 · SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - AMAM, TGAN, CSTR, THRX · Persbericht

22 december 2023 · Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right · Persbericht

7 november 2023 · Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conference · Persbericht

10 augustus 2023 · Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results · Persbericht

13 juli 2023 · Theseus Pharmaceuticals to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GIST · Persbericht

31 mei 2023 · Theseus Pharmaceuticals to Participate in the Jefferies Healthcare Conference · Persbericht

25 mei 2023 · Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST · Persbericht

11 mei 2023 · Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results · Persbericht

26 april 2023 · Theseus Pharmaceuticals Initial Dose Escalation Results from Ongoing Phase 1/2 Trial of THE-630 Accepted for Online Publication at 2023 ASCO Annual Meeting · Persbericht

Profiel Theseus Pharmaceuticals Inc

Werknemers: 3

Aandelen Theseus Pharmaceuticals Inc

Effecten: 44,23 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe